Gilde Healthcare leads USD 20 million financing round of Belgian sleep therapy company Nyxoah
Target: Nyxoah S.A.
Branch: medical devices
Buyer: Gilde Healthcare, SRIW
Transaction: Nyxoah S.A., a medical device company focused on developing a neurostimulation based, disruptive therapy for patients suffering from Obstructive Sleep Apnea (OSA), announced today it has raised €18 million ($20 million) in fresh capital. The financing was led by Gilde Healthcare. SRIW and all existing shareholders also participated in the round. The proceeds will be used to finance Nyxoah’s go-to-market strategy, including CE Mark approval and the US FDA approval process….